C07K 2319/02
Containing a signal sequence
Official title: containing a signal sequence
C07K2319/02 (Containing a signal sequence) appears on 3,740 US grants and 5,033 published applications in this corpus.
Search patents in C07K- Granted patents
- 3,740
- Published applications
- 5,033
- Assignees
- 2,185
- Inventors
- 10,363
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 10 | 0 |
| 1987 | 17 | 0 |
| 1988 | 18 | 0 |
| 1989 | 24 | 0 |
| 1990 | 26 | 0 |
| 1991 | 36 | 0 |
| 1992 | 48 | 0 |
| 1993 | 65 | 0 |
| 1994 | 57 | 0 |
| 1995 | 52 | 0 |
| 1996 | 94 | 0 |
| 1997 | 114 | 0 |
| 1998 | 178 | 0 |
| 1999 | 159 | 0 |
| 2000 | 130 | 0 |
| 2001 | 105 | 11 |
| 2002 | 102 | 150 |
| 2003 | 82 | 227 |
| 2004 | 57 | 140 |
| 2005 | 71 | 121 |
| 2006 | 87 | 90 |
| 2007 | 69 | 64 |
| 2008 | 56 | 64 |
| 2009 | 52 | 69 |
| 2010 | 52 | 71 |
| 2011 | 48 | 62 |
| 2012 | 42 | 54 |
| 2013 | 42 | 85 |
| 2014 | 55 | 83 |
| 2015 | 43 | 88 |
| 2016 | 90 | 130 |
| 2017 | 81 | 174 |
| 2018 | 97 | 235 |
| 2019 | 118 | 267 |
| 2020 | 146 | 315 |
| 2021 | 165 | 437 |
| 2022 | 207 | 439 |
| 2023 | 184 | 453 |
| 2024 | 230 | 482 |
| 2025 | 252 | 425 |
| 2026 | 173 | 297 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Non-viral transcription activation domains and methods and uses related thereto6 Oct 2026US 12,753,212 B2Teknologian tutkimuskeskus VTT Oy
- Mesothelin specific chimeric antigen receptors (CAR) for solid tumors cancer immunotherapy6 Oct 2026US 12,753,220 B2Cellectis
- Vector for co-expressing genes of interest6 Oct 2026US 12,753,414 B2Gat Biosciences, S.L.
- Universal chimeric antigen expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders29 Sep 2026US 12,747,277 B2AvenCell Europe GmbH
- Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof29 Sep 2026US 12,747,279 B2Abelzeta Inc.
- Influenza estem immunogens8 Oct 2026US 2026/0306612 A1
- Chimeric receptors8 Oct 2026US 2026/0306631 A1St. Jude Children?S Research Hospital
- Fusion proteins of il-24 and immunostimulatory cytokines, nk cells expressing il-24 or fusion proteins, and methods of use thereof8 Oct 2026US 2026/0308218 A1Virginia Commonwealth University
- Targeted engineered interferon and uses thereof8 Oct 2026US 2026/0308221 A1Orionis Biosciences BV
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
Most cited
By later US patents
- Recombinant immunoglobin preparations4,785US 4,816,567 AGenentech, Inc. · 1989
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001